Orphai Therapeutics
At OrphAI Therapeutics, we are focused on identifying and developing innovative therapeutics. Our current clinical stage drug candidates target Group 1 and Group 3 Pulmonary Hypertension and bronchiolitis obliterans syndrome post lung transplant.
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
11
1 to 10 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 8 verified contacts at Orphai Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
- BR
Brigette Roberts
Chief Executive Officer · General Business & Management
EmailPhone - JH
Joel Hale
Vice President, Clinical Operations · Operations
EmailPhone
Showing 2 of 8 verified contacts
Top roles at Orphai Therapeutics
6 distinct titles indexed · top 6 shown.
- 1chief executive officer
- 1laborer
- 1molecular and cell biology research associate
- 1professional driver
- 1technicien
- 1vice president, clinical operations
Sign up to unlock all 8 contacts at Orphai Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Orphai Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.